循環器内科専門医バイブル 3 不整脈 識る・診る・治す

出版社: 中山書店
著者:
発行日: 2018-10-17
分野: 臨床医学:内科  >  循環器一般
ISBN: 9784521745855
電子書籍版: 2018-10-17 (初版第1刷)
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安:8~14営業日

13,200 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

13,200 円(税込)

商品紹介

循環器専門医と専門医を目指す医師のための新シリーズ第3弾.多数に細分類される不整脈の全領域にわたり,診療に必須の広範な知識と的確な診断法,治療薬やデバイスの使いこなし方,病態に応じた治療の実際,さらに最新機器が臨床応用されている診療の最新動向に至るまで,第一線の整脈専門医が詳しく解説.常に座右に置いて指針を仰ぐにふさわしい,「バイブル」の名に値する実践書.

目次

  • 序章 不整脈オーバービュー
     不整脈専門領域の拡大―過去,現在,未来
     不整脈薬物治療の変遷

    第1章 不整脈を識る―不整脈の基礎
     不整脈の分類
     不整脈の疫学
     不整脈の発生機序
     臨床研究のエビデンス

    第2章 不整脈を診る―不整脈の診断
     臨床症状と診断のフローチャート
     問診/身体所見のとり方
     標準12誘導心電図から何がわかるか
     心電図検査
      a.ホルター心電図
      b.運動負荷心電図
     チルト試験
     加算平均心電図とT波オルタナンス
     心エコー
     CT/MRI/PET
     臨床電気生理学的検査
     遺伝性不整脈の遺伝子検査
     鑑別診断のポイント

    第3章  不整脈を治す―薬物治療と非薬物治療
     徐脈(洞不全症候群/房室ブロック)
     期外収縮
     心房頻拍/心房粗動
     心房細動
     発作性上室頻拍/早期興奮症候群
     心室頻拍
     心室細動
     まれな心室頻脈/心室細動:Brugada症候群など
     遠隔モニタリング
     チーム医療

    第4章 Expert Advice-治療薬やデバイスの一歩進んだ使い方・使いこなし方
     抗不整脈薬
     抗凝固薬
     ペースメーカ治療―デバイス植込み症例における遠隔モニターと心原性脳梗塞の予防
     ICD/CRT-D
     デバイス抜去術
     放射線被曝低減

    第5章 さまざまな不整脈-病態に応じた治療の実際
     不全心を伴った不整脈
      a.心房細動
      b.心室頻拍/細動
     虚血心における不整脈
     肥大型心筋症における不整脈
     不整脈原性右室心筋症における不整脈
     Brugada症候群/J波症候群における不整脈
     小児の不整脈(QT延長症候群カテコラミン/誘発多形性心室頻拍)
     外科手術後の不整脈

    第6章 Current Topics-診断と治療の最新動向
     S-ICD
     非薬物的左心耳血栓予防
     潜因性脳梗塞診断
     リードレスペースメーカ
     カテーテルアブレーションにおけるhigh density 3Dマッピングの実際
     レーザーバルーンアブレーション

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

序章 不整脈オーバービュー

P.8 掲載の参考文献
1) Tawara S. Das Reizleitungssystem des Saugetierherzens. Eine anatomisch-histologische Studie uber das Atrioventrikularbundel and die Purkinjeschen Faden. Fischer G ; 1906.
2) Scherlag BJ, et al. Catheter technique for recording His bundle activity in man. Circulation 1969 ; 39 : 13-8.
3) Vaughan Williams EM. Classification of antiarrhythmic drugs. In : Sandoe E, et al, editors. Symposium on Cardiac Arrhythmias. Sodertalje Astra ; 1970, p. 449-72.
4) CAST Investigators, Preliminary report : Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989 ; 321 : 406-12.
5) 岩喬ほか. Wolff-Parkinson-White症候群の外科治療. 胸部外科 1970 ; 23 : 513-7.
6) Guiraudon G, et al. Encircling endocardial ventriculotmy : A new surgical treatment for life-threatening ventricular tachycardias resisitant to medical treatment following myocardial infarction. Ann Thorac Surg 1978 ; 26 : 438-44.
7) Scheinman MM, et al. Catheter-induced ablation of the atrioventricular junction to control refractory supraventricular arrhythmias. JAMA 1982 ; 248 : 851-5.
8) Jackman WM, et al. Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current. N Engl J Med 1991 ; 324 : 1605-11.
9) Cox JL, et al. The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg 1991 ; 101 : 569-83.
12) Shirai Y, et al. Elimination of ventricular arrhythmia in cathecholaminergic polymorphic ventricular tachycardia by targeting "cathecholamine-sensitive area". Pacing Clin Electrophysiol 2017 ; 40 : 600-4.
P.16 掲載の参考文献
1) Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report : Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989 ; 321 : 406-12.
2) International mexiletine and placebo antiarrhythmic coronary trial : I. Report on arrhythmia and other findings. Impact Research Group. J Am Coll Cardiol 1984 ; 4 : 1148-63.
3) Yamashita T, et al. Dose-response effects of bepridil in patients with persistent atrial fibrillation monitored with transtelephonic electrocardiograms : A multicenter, randomized, placebo-controlled, double-blind study (J-BAF Study), Circ J 2009 ; 73 : 1020-7.
4) Atarashi H, et al. Conversion of recent-onset Atrial Fibrillation by a single oral dose of Pilsicainide (Pilsicainide Suppression Trial on atrial fibrillation). Am J Cardiol 1996 ; 78 : 694-7.
7) Tieleman RG, et al. Digoxin delays recovery from tachycardia-induced electrical remodeling of the atria. Circulation 1999 ; 100 : 1836-42.
8) Sticherling C, et al. Effects of digoxin on acute, atrial fibrillation-induced changes in atrial refractoriness. Circulation 2000 ; 1102 : 2503-8.
9) Murgatroyd FD, et al. Double-blind placebo-controlled trial of digoxin in symptomatic paroxysmal atrial fibrillation. Circulation 1999 ; 99 : 2765-70.
10) Atarashi H, et al. Double-blind placebo-controlled trial of aprindine and digoxine for the prevention of symptomatic atrial fibrillation. Circ J 2002 ; 66 : 553-6.
12) Kotecha D, et al. Efficacy ofβblockers in patients with heart failure plus atrial fibrillation : An individual-patient data meta-analysis. Lancet 2014 ; 384 : 2235-43.
15) Ogawa S, et al. Optimal treatment strategy for patients with artrial fibrillation : J-RHYTHM Study. Circ J 2009 ; 73 : 242-8.
17) Inoue H, et al. Target international normalized ratio values for preventing thromboembolic and hemorrhagic events in Japanese patients with non-valvular atrial fibrillation : Results of the J-RHYTHM Registry. Circ J 2013 ; 77 : 2264-70.
18) Akao M, et al. Current status of clinical background of patients with atrial fibrillation in a community-based survey : The Fushimi AF Registry. J Cardiol 2013 ; 61 : 260-6.
19) Ruff CT, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation : A mata-analysis of randomized trials. Lancet 2014 ; 383 : 955-62.
20) Efficacy and Safety of Intranasol MSP-2017 (Etripamil) for the Conversion of PSVT to Sinus Rhythm (NODE-1). www.clinicaltrials.gov. NCT02296190.

第1章 不整脈を識る - 不整脈の基礎

P.24 掲載の参考文献
奥村謙. ステップで判読! 心電図. 南江堂 ; 2007.
P.32 掲載の参考文献
1) Ahlbom A, Norell S. Introduction to Modern Epidemiology. 2nd edition. Epidemiology Resources ; 1990. p. 1,
2) 杉本恒明. 心房細動の疫学, 早川弘一, 笠貫宏編. 心房細動・粗動・頻拍. 医学書院 ; 1999.
3) Ohsawa M, et al. Rapid increase in estimated number of persons with atrial fibrillation in Japan : An analysis from national surveys on cardiovascular diseases in 1980, 1990 and 2000. J Epidemiol 2005 ; 15 : 194-6.
4) Shimizu A. Genesis and the Risk Score of A trial Fibrillation for Personalized Management. Circ J 2017 ; 81 : 1574-5.
6) 鼠尾祥三ほか. 学童不整脈の臨床的検討-その頻度, 再現性, 他の心疾患の合併, 運動負荷に対する反応. 心電図 1985 ; 5 : 375-81.
P.42 掲載の参考文献
1) Rubart M, Zipes DP. Genesis of cardiac arrhythmia : Electrophysiological considerations. In : Mann DL, et al, editors. Braunwald's Heart Disease : A Textbook of Cardiovascular Medicine. 10th edition. Elsevier ; 2015. p. 629-61.
2) Jalife J, et al. Basic mechanisms of cardiac arrhythmias. In : Jalife J, et al, editors. Basic Cardiac Electrophysiology for the Clinician. 2nd edition. Wiley-Blackwell ; 2009. p, 152-90.
9) Yoshida Y, et al. Antiarrhythmic efficacy of dipyridamole in treatment of reperfusion arrhythmias : Evidence for cAMP-mediated triggered activity as a mechanism responsible for reperfusion arrhythmias. Circulation 2000 ; 101 : 624-30.
12) Prust MJ, et al. Mechanisms of cardiac arrhythmias, In : Lilly LS, editor. Pathophysiology of Heart Disease : A Collaborative Project of Medical Students and Faculty. 6th edition, Wolters Kluwer ; 2016, p. 268-86.
14) Narayan SM, et al. Treatment of atrial fibrillation by the ablation of localized sources : CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial. J Am Coll Cardiol 2012 ; 14 : 60 : 628-36.
P.48 掲載の参考文献
1) Echt DS, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991 ; 324 : 781-8.
2) Burkart F, et al. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias : Basel Antiarrhythmic Study of Infarct Survival (BASIS). J Am Coll Cardiol 1990 ; 16 : 1711-8.
4) Moss AJ, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996 ; 335 : 1933-40.
6) Bigger JT Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med 1997 ; 337 : 1569-75.
7) Connolly SJ, et al. Canadian implantable defibrillator study (CIDS) : A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000 ; 101 : 1297-302.
8) Domanski MJ for the AVID Investigators. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. J Am Coll Cardiol 1999 ; 34 : 1090-5.
9) Bardy GH, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005 ; 352 : 225-37.
11) Rov D, et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 2008 ; 358 : 2667-77.
17) Kotecha D, et al. Efficacy of β blockers in patients with heart failure plus atrial fibrillation : An individual-patient data meta-analysis. Lancet 2014 ; 384 : 2235-43.

第2章 不整脈を診る - 不整脈の診断

P.57 掲載の参考文献
1) 杉薫. 緊急治療を要しない不整脈. 治療 2000 : 82 : 54-9.
2) Bayes de Luna A, et al. Ambulatory sudden cardiac death : Mechanisms or production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 1989 ; 117 : 151-9.
3) Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death : A distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992 ; 20 : 1391-6.
P.70 掲載の参考文献
1) Galvani L. Aloysii Galvani de Viribus Electricitatis in Motu Musculari Commentarius, Ex Typographia Instituti Scientiarium, Bononiae, 1791.
2) Caton R, The electrical currents of the brain, British Medical Journal 1875 ; 2 (765) : 278. doi : 10.1136/bmj2.765.257.
3) Berger H. Uber das Elektrenkephalogramm des Menschen. Archiv fur Psychiatrie und Nervenkrankheiten 1929 ; 87 : 527-70.
4) Scholz F. Electroanalytical Methods : Guide to Experiments and Applications. 2nd ed. Springer ; 2010.
5) Einthoven W. Galvanometrische registratie van het menschelijk electrocardiogram. In : Herinneringsbudendedl Professor S. S. Rosenstein. Eduard Ijdo ; 1902. p. 101-7.
6) Waller AD. A demonstration on man of electromotive changes accompanying the heart's beat. J Physiol 1887 ; 8 : 229-34.
7) Waller AD. On the electromotive changes connected with the beat of the mammalian heart and on the human heart in particular. Phil Tran Roy SocLondon 1889 ; 180 : 169-94.
8) Einthoven W. Weiteres Uber das Elektrokardiogram. Pfluger Arch ges Physiol 1908 ; 122 : 517-48.
9) Einthoven W, et al, Uber die Richtung und die Manifeste Grosse der Potentialschwankungen im mennschlichen Herzen und uber den Einfluss der Herzlage auf die form des Elektrokardiogramms. Pfluger Arch ges Physiol 1913 ; 150 : 275-315.
10) Wilson FN, et al. Electrocardiograms that represent the potential variations of a single electrode. Am Heart J 1934 ; 9 : 447-71.
11) Goldberger E. A simple indifferent electrocardiographic electrode of zero potential and a technique of obtaining augmented, unipolar extremity leads. Am Heart J 1942 ; 23 : 483-92.
12) Wilson FN, et al. The precordial electrocardiogram. Am Heart J 1944 ; 27 : 19-85.
13) Hurst JW. Naming of the waves in the ECG, with a brief account of their genesis. Circulation 1998 ; 98 : 1937-42.
15) Vereckei A. Current algorithms for the diagnosis of wide QRS complex tachycardias. Curr Cardiol Rev 2014 ; 10 : 262-76.
16) Blomstrom-Lundqvist C, et al. ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias*-Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias). Developed in Collaboration with NASPE-Heart Rhythm Society. JACC 2003 ; 42 : 1493-531.
17) 夛田浩. 12 誘導心電図波形を用いた特発性心室不整脈起源の診断. 心電図 2010 ; 30 : 453-65.
18) 日本循環器学会. 循環器病の診断と治療に関するガイドライン (2009年度合同研究班報告) : 慢性虚血性心疾患の診断と病態把握のための検査法の選択基準に関するガイドライン (2010年改訂版). http://www.j-circ.or.jp/guideiine/pdf/JCS2010_yamagishi_h.pdf
20) Cowan JC, et al. Importance of lead selection in QT interval measurement. Am J Cardiol 1988 ; 61 : 83-7.
21) Malik M, et al. Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol 2000 ; 36 : 1749-66.
22) Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 1949 ; 37 : 161-86.
23) Casale PN, et al. Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms : Validation with autopsy findings. Circulation 1987 ; 75 : 565-72.
24) Romhilt W, Estes EH Jr. A point-score system for the ECG diagnosis of left ventricular hypertrophy. Am Heart J 1968 ; 75 : 752-8.
25) Hancock EW, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram : Part V : Electrocardiogram changes associated with cardiac chamber hypertrophy : A scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee. Council on Clinical Cardiology ; the American College of Cardiology Foundation ; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol 2009 ; 53 : 992-1002.
P.80 掲載の参考文献
1) Holter NJ. Radioelectrocardiography : A new technique for cardiovascular studies. Ann N Y Acad Sci 1957 ; 65 : 913-23.
2) Crawford MH, et al. ACC/AHA Guidelines for Ambulatory Electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography). Developed in collaboration with the North American Society for Pacing and Electrophysiology. J Am Coll Cardiol 1999 ; 34 : 912-48.
3) 石川利之. Holter心電図を臨床にどういかすか? . Heart view 2016 ; 20 : 78-85.
4) Bjerregaard P. Premature beats in healthy subjects 40-79 years of age. Eur Heart J 1982 ; 3 : 493-503.
5) 日本循環器学会. 循環器の診断と治療に関するガイドライン (2009年度合同研究報告) 慢性虚血性心疾患の診断と病態把握のための検査法の選択基準に関するガイドライン (2010年改訂版). www.j-circ.or.jp/guideline/pdf/JCS2010_yamagishi_h.pdf
6) Arntz HR, et al, Circadian variation of sudden cardiac death reflects age-related variability in ventricular fibrillation. Circulation 1993 ; 88 (5 Pt 1) : 2284-9.
7) Bayes de Luna A, et al. Ambulatory sudden cardiac death : Mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 1989 ; 117 : 151-9.
8) Hodges M, Bailey JJ. Ambulatory electrocardiography : Use in arrhythmia risk assessment, In : Malik M, editor. Risk of Arrhythmia and Sudden Death. BMJ Publishing ; 2001. p. 194-201.
9) La Rovere MT, et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes after Myocardial Infarction) Investigators. Lancet 1998 ; 351 : 478-84.
P.87 掲載の参考文献
2) 日本循環器学会, 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告). 不整脈の非薬物治療ガイドライン (2011年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2011_okumura_h.pdf
4) 日本循環器学会. 循環器病の診断と治療に関するガイドライン (2011年度合同研究班報告) : QT延長症候群 (先天性・二次性) とBrugada症候群の診療に関するガイドライン (2012年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2013_aonuma_h.pdf
5) 厚生労働省. 身体障害者手帳. http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/hukushi_kaigo/shougaishahukushi/shougaishatechou/
P.93 掲載の参考文献
3) The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC). Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J 2009 ; 30 : 2631-71.
4) Mann D, et al. Braunwald's Heart Disease : A Textbook of Cardiovascular Medicine. 10th edition. Vol. 1, 2. Elsevier Saunders : 2014.
6) Sheldon R, et al. Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope. Circulation 1996 ; 93 : 973-81.
7) 日本循環器学会. 循環器病の診断と治療に関するガイドライン (2011年度合同研究班報告) : 失神の診断・治療ガイドライン (2012年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2012_ioue_h.pdf
8) Sumiyoshi M, et al. Poor reproducibility of false-positive tilt testing results in healthy volunteers. Jpn Heart J 1999 ; 40 : 71-8.
9) Brignole M, et al. Pacemaker therapy in patients with neurally mediated syncope and documented asystole : Third International Study on Syncope of Uncertain Etiology (ISSUE-3) : A randomized trial, Circulation 2012 ; 125 : 2566-71.
P.102 掲載の参考文献
1) 日本循環器学会. 循環器病の診断と治療に関するガイドライン (2009年度合同研究班報告) 心臓突然死の予知と予防法のガイドライン (2010年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2010aizawa.h.pdf
2) 池田隆徳ホルター心電図による心イベントの予測. 井上博編. Medical Topics Series 不整脈 2013. メディカルレビュー社 ; 2013, p. 177-90.
3) 池田隆徳. 加算平均心電図法. 村川裕二編, 心電図. 新 目でみる循環器病シリーズ 1. メジカルビュー社 ; 2005, p. 174-87.
4) 池田隆徳. 遅延電位 (late potentials). 北風政史編. ICDとCRT-Dの臨床-心不全・致死性不整脈への対応. 循環器臨床サピア 3. 中山書店 : 2009, p. 30-5.
5) ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death : A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2006 ; 48 (5) : e247-346.
6) JCS Joint Working Group. Guidelines for risks and prevention of sudden cardiac death (JCS2010) : Digest version. Circ J 2012 ; 76 : 489-507.
7) 池田隆徳. T-wave alternans (TWA). 田邉晃久編, 心臓突然死を予知するための不整脈ノンインベイシブ検査. 医学書院 ; 2010, p. 221-40.
8) 池田隆徳. T波交互現象 (T-wave alternans) の意義と展望. 井上博編. Medical Topics Series 不整脈 2011. メディカルレビュー社 ; 2011, p. 158-75,
9) Verrier RL, et al. Microvolt T-wave alternans : Physiologic basis, methods of measurement, and clinical utility : Consensus guideline by the International Society for Holter and Noninvasive Electrocardiology. J Am Coll Cardiol 2011 ; 58 : 1309-24.
P.109 掲載の参考文献
4) Romero J, et al. Detection of left atrial appendage thrombus by cardiac computed tomography in patients with atrial fibrillation : A meta-analysis. Circ Cardiovasc Imaging 20 ; 316 : 185-94.
6) Seo Y, et al. Clinical utility of 3-dimensional echocardiography in the evaluation of tricuspid regurgitation caused by pacemaker leads, Circ J 2008 ; 72 : 1465-70.
7) Ishizu T, et al. Noninvasive localization of accessory pathways in Wolff-Parkinson-White Syndrome by three-dimensional speckle tracking echocardiography. Circ Cardiovasc Imaging 2016 ; 9. pii : e004532. doi : 10.1161/CIRCIMAGING. 116. 004532.
P.118 掲載の参考文献
P.128 掲載の参考文献
1) Knight BP, et al. Diagnostic value of tachycardia features and pacing maneuvers during paroxysmal supraventricular tachycardia. J Am Coll Cardiol 2000 ; 36 : 574-82.
3) Maruyama M, et al. The VA relationship after differential atrial overdrive pacing : A novel tool for the diagnosis of atrial tachycardia in the electrophysiologic laboratory. J Cardiovasc Electrophysiol 2007 ; 18 : 1127-33.
4) Hirao K, et al, Para-Hisian pacing. A new method for differentiating retrograde conduction over an accessory AV pathway from conduction over the AV node. Circulation 1996 ; 94 : 1027-35.
6) Waldo AL, et al. Entrainment and interruption of atrial nutter with atrial pacing : Studies in man following open heart surgery, Circulation 1977 ; 56 : 737-45.
7) Stevenson WG, et al. Entrainment techniques for mapping atrial and ventricular tachycardias. J Cardiovasc Electrophysiol 1995 ; 6 : 201-16.
8) Henthorn RW, et al. A fourth criterion for transient entrainment : The electrogram equivalent of progressive fusion. Circulation 1988 ; 77 : 1003-12.
10) EL-Sherif N, et al. Reentrant ventricular arrhythmias in the late myocardial infarction period : 14. Mechanisms of resetting, entrainment, acceleration, or termination of reentrant tachycardia by programmed electrical stimulation. Pacing Clin Electrophysiol 1987 ; 10 : 341-71.
11) Stevenson WG, et al. Entrainment techniques for mapping atrial and ventricular tachycardias. J Cardiovasc Electrophysiol 1995 ; 6 : 201-16.
P.135 掲載の参考文献
1) アジレント・テクノロジー株式会社, ClearSeq Halo心筋症リサーチパネル, http://www.chem-agilent.com/contents.php?id=1003441#HaloPlex02
3) National Human Genome Research Institute. The cost of sequencing a human genome. https://www.genome.gov/27565109/the-cost-of-sequencing-a-human-genome
4) Tfelt-Hansen J, et al. Inherited cardiac diseases caused by mutations in the Nav 1, 5 sodium channel. J Cardiovasc Electrophysiol 2010 ; 21 : 107-15.
5) Vatta M, et al. Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Hum Mol Genet 2002 ; 11 : 337-45.
6) Human Genetic Variation Database (HGVD). http://www.hgvd.genome.med.kyoto-u.ac.jp/
7) Tohoku University Tohoku Medical Megabank Organization (ToMMo). https://ijgvd.megabank.tohoku.ac.jp/search/
P.142 掲載の参考文献
1) Brugada P, et al. A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex. Circulation 1991 ; 83 : 1649-59.
三田村秀雄ほか. エキスパートはここを見る 心電図読み方の極意. 南山堂 ; 2016.

第3章 不整脈を治す - 薬物治療と非薬物治療

P.151 掲載の参考文献
1) Evans R, Shaw DB. Pathological studies in sinoatrial disorder (sick sinus syndrome). Br Heart J 1977 ; 39 : 778-86.
2) Thery C, et al. Pathology of sinoatrial node. Correlation with electrocardiographic findings in 111 patients. Am Heart J 1977 ; 93 : 735-40.
3) Sugiura M, Ohkawa S. A clinicopathologic study on sick sinus syndrome with histological approach to the sinoatrial node. Jpn Circ J 1980 ; 44 : 497-504.
4) 戸叶隆司ほか, 洞機能不全症候群における右心房不応期のdispersionに関する検討. 心電図 2004 ; 24 : 49-58.
5) Josephson ME. Sinus node function. In : Jasephson ME. Clinical Cardiac Electrophysiology : Techniques and Interpretations. 2nd edition. Lea & Febliger ; 1993, p. 71-95.
6) 八木洋ほか. 洞自動能, 洞房伝導能に対するoverdrive suppressionの臨床的意義と自律神経系のoverdrive suppressionに及ぼす影響-洞結節電位記録法による検討. 心電図 1996 ; 16 : 360-8.
7) Rubenstein JJ, et al. Clinical spectrum of the sick sinus syndrome. Circulation 1972 ; 46 ; 5-13.
8) Josephson ME. Atrioventricular conduction, intraventricular conduction disturbances. In : Clinical Cardiac Electrophysiology : Techniques and Interpretations. 2nd edition. Lea & Febiger ; 1993, p. 96-149.
9) 中田八洲郎. 房室ブロック. 早川弘一, 比江嶋一昌編, 臨床心臓電気生理学. 改訂第3版. 南江堂 ; 2001, p. 85-109.
10) Sumiyoshi M, et al. Clinical and electrophysiologic features of exercise-induced atrioventricular block. Am Heart J 1996 ; 132 : 1277-81.
11) 戸叶隆司, 住吉正孝. 潜在性房室ブロックの診断と治療 カレントテラピー 1995 ; 13 : 46-52.
12) 戸叶隆司ほか. 一過性房室ブロック例におけるIa群抗不整脈剤静注による房室ブロック誘発に関する検討. 心臓 1997 ; 29 : 193-204.
13) 中里祐二, 中田八洲郎. 高度および完全房室ブロックにおける臨床電気生理学的検討. 心臓ペーシング 1987 ; 3 : 355-63.
14) 日本循環器学会. 循環器病の診断と治療に関するガイドライン (2005年度合同研究班報告) : 不整脈の非薬物治療ガイドライン (2006年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2006_kasanuki_h.pdf
15) 日本循環器学会. 循環器病の診断と治療に関するガイドライン : 循環器医のための心肺蘇生・心血管救急に関するガイドライン. Circ J 2009 ; 73 : 1361-456.
P.159 掲載の参考文献
1) McGuire MA, et al. Atrioventricular junctional tissue. Discrepancy between histological and electrophysiological characteristics. Circulation 1996 ; 94 : 571-7.
4) 日本循環器学会. 循環器病の診断と治療の関するガイドライン (2010年度合同研究班報告) : 不整脈の非薬物治療ガイドライン (2011年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2011_okumura_h.pdf
P.165 掲載の参考文献
Lipman BS, et al. General comments of interpretation. In : Lipman M, et al. Clinical Electrocardiography, 7th edition. Year Book Medical Publishers ; 1984, p. 326-75.
Khan MG. The P wave. In : Kahn MG. Rapid ECG Interpretation, 2nd edition. Saunders : 2003, p. 89-94
庭野慎一. P波の成り立ちと, 波形の特徴が示すもの. レジデント 2014 ; 7 : 6-11.
P.171 掲載の参考文献
1) 日本循環器学会. 循環器の診断と治療に関するガイドライン (2012年度合同研究班報告) : 心房細動治療 (薬物) ガイドライン (2013年改訂版), http://www.j-circ.or.jp/guideline/pdf/JCS2013_inoue_h.pdf
2) Wyse DG, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. N Engl J Med 2002 ; 347 : 1825-33.
3) Kato T, et al. Progressive nature of paroxysmal atrial fibrillation. Observations from a 14-year follow-up study. Circ J 2004 ; 68 : 568-72.
4) Haissaguerre M, et al. Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation 2000 ; 102 : 2463-5.
P.181 掲載の参考文献
1) 日本循環器学会. 循環器病の診断と治療に関するガイドライン (2008年度合同研究班報告) : 不整脈薬物治療に関するガイドライン (2009年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2009_kodama_h.pdf
2) 日本循環器学会. 循環器病の診断と治療に関するガイドライン (2010-2011年度合同研究班報告) : カテーテルアブレーションの適応と手技に関するガイドライン. http://www.j-circ.or.jp/guideline/pdf/JCS2012_okumura_h.pdf
3) Calkins H. Radiofrequency catheter ablation of supraventricular arrhythmias. Heart 2001 ; 85 : 594-600,
5) Yamane T, et al. Optimal target site for slow AV nodal pathway ablation : Possibility of predetermined focal mapping approach using anatomic reference in the Koch's triangle. J Cardiovasc Electrophysiol 1999 ; 10 : 529-37.
P.190 掲載の参考文献
1) Brugada P, et al. A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex. Circulation 1991 ; 83 : 1649-59.
2) Nogami A, Tada H. Ablation of idiopathic left and right ventricular and fascicular tachycardias. In : Huang S, Miller J, editors. Catheter Ablation of Cardiac Arrhythmias. 3rd edition. Elsevier/Saunders : 2015, p. 540-78.
3) 日本循環器学会. 循環器の診断と治療に関するガイドライン (2008年度合同研究班報告). 不整脈薬物治療に関するガイドライン (2009年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2009_kodama_h.pdf
7) Do DH, et al. Thoracic epidural anesthesia can be effective for the short-term management of ventricular tachycardia storm. J Am Heart Assoc 2017 ; 6 (11). pii : e007080. doi : 10.1161/JAHA.117. 007080.
8) Dukkipati SR, et al. Catheter ablation of ventricular tachycardia in structurally normal hearts : Indications, strategiest and outcomes-Part I. J Am Coll Cardiol 2017 ; 70 : 2909-23.
9) Dukkipati SR, et al. Catheter ablation of ventricular tachycardia in structural heart disease : Indications, strategies, and outcomes-Part II. J Am Coll Cardiol 2017 ; 70 : 2924-41.
Kudenchuk PJ, et al ; Resuscitation Outcomes Consortium Investigators. Amiodarone. Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest. N Engl J Med 2016 ; 374 : 1711-22.
P.197 掲載の参考文献
1) Priori SG, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death : The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by : Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 2015 ; 36 : 2793-867.
3) 日本循環器学会. 循環器病の診断と治療に関するガイドライン (2011年度合同研究班報告) : QT延長症候群 (先天性・二次性) とBrugada症候群の診療に関するガイドライン (2012年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2013_aonuma_h.pdf
4) 日本循環器学会. 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告) : 不整脈の非薬物治療ガイドライン (2011年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2011_okumura_h.pdf
6) Miyazaki S, et al. How to ablate ventricular fibrillation arising from structurally normal heart. In : Al-ahmad A, et al. editors. Hands-on Ablation : The Experts' Approach. Cardiotext ; 2013, p. 428-34.
P.206 掲載の参考文献
1) Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death : A distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992 ; 20 : 1391-6.
3) Antzelevitch C, et al. J-Wave syndromes expert consensus conference report : Emerging concepts and gaps in knowledge. Heart Rhythm 2016 ; 13 : e295-324.
4) 日本循環器学会. 2016-2017年活動 : 遺伝性不整脈の診療に関するガイドライン (2017年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2017_aonuma_h.pdf
8) Priori SG, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death : The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by : Association for European Paediatric and Congenitat Cardiology (AEPC). Eur Heart J 2015 ; 36 : 2793-867.
9) Al-Khatib SM, et al. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death : Executive Summary : A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm, 2017 Oct 30. pii : S1547-5271 (17) 31249-3. doi : 10.1016/j. hrthm. 2017. 10. 035.
P.212 掲載の参考文献
P.220 掲載の参考文献
1) Varma N, et al. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up : The Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation 2010 ; 122 : 325-32.
7) Peterson ED, et al. Implementing critical pathways and a multidisciplinary team approach to cardiovascular disease management. Am J Cardiol 2008 ; 102 (5A) : 47G-56G.
8) 鈴木誠. チームで取り組む医療のキホン-よりよい患者ケアのために, 鈴木誠, 編著. チームで取り組む心臓デバイス植込み患者のケアとマネジメント-遠隔モニタリングの活用から一般管理まで. 南江堂 ; 2012, p. 2-5.
9) Kinugasa Y, et al. Multidisciplinary intensive education in the hospital improves outcomes for hospitalized heart failure patients in a Japanese rural setting. BMC Health Serv Res 2014 ; 14 : 351.

第4章 Expert Advice - 治療薬やデバイスの一歩進んだ使い方・使いこなし方

P.229 掲載の参考文献
1) Komatsu T. Current strategies of antiarrhythmic drug therapy for paroxysmal atrial fibrillation. J Arrhythmia 2012 ; 28 : 162-9.
2) 日本循環器学会. 循環器病の診断と治療に関するガイドライン (2012年度合同研究班報告) : 心房細動治療 (薬物) ガイドライン (2013年改訂版). Circ J 2014 ; 78 : 1997-2021. http://www.j-circ.or.jp/guideline/pdf/JCS2013_inoue_h.pdf
3) Yamashita T, et al. Dose-response effects of bepridil in patients with persistent atrial fibrillation monitored with transtelephonic electrocardiograms : A multicenter, randomized, placebo-controlled, double-blind study (J-BAF study). Circ J 2009 ; 73 : 1020-7.
7) Miwa Y, et al. Effects of landiolol, an ultra-short-acting β 1-selective blocker, on electrical storm refractory to class III antiarrhythmic drugs. Circ J 2010 ; 74 : 856-63.
8) Velebit V, et al. Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs. Circulation 1982 ; 65 : 886-94.
P.235 掲載の参考文献
1) Olesen JB, Torp-Pedersen C. Stroke risk in atrial fibrillation : Do we anticoagulate CHADS2 or CHA2DS2-VASc ≧ 1. or higher? Thromb Haemost 2015 ; 113 : 1165-9.
2) Suzuki S, et al. Incidence of ischemic stroke in Japanese patients with atrial fibrillation not receiving anticoagulation therapy--pooled analysis of the Shinken Database, J-RHYTHM Registry, and Fushimi AF Registry. Circ J 2015 ; 79 : 432-8.
3) Kodani E, et al. Impact of blood pressure control on thromboembolism and major hemorrhage in patients with nonvalvular atrial fibrillation : A subanalysis of the J-RHYTHM Registry. J Am Heart Assoc 2016 ; 5.
4) Ishii M, et al. Relationship of hypertension and systolic blood pressure with the risk of stroke or bleeding in patients with atrial fibrillation : The Fushimi AF Registry. Am J Hypertens 2017 ; 30 : 1073-82.
6) O'Brien EC, et al. The ORBIT bleeding score : A simple bedside score to assess bleeding risk in atrial fibrillation. Eur Heart J 2015 ; 36 : 3258-64.
9) Akao M, et al. Inappropriate use of oral anticoagulants for patients with atrial fibrillation. Circ J 2014 ; 78 : 2166-72.
10) Inoue H, et al. Post-marketing surveillance on the long-term use of dabigatran in Japanese patients with nonvalvular atrial fibrillation : Preliminary report of the J-dabigatran surveillance. J Arrhythm 2016 ; 32 : 145-50.
14) Okumura K, et al. Time in the therapeutic range during warfarin therapy in Japanese patients with non-valvular atrial fibrillation. -A multicenter study of its status and infuential factors. Circ J 2011 ; 75 : 2087-94.
15) J-Rhythm Registry Investigators. Determinants of warfarin use and international normalized ratio levels in atrial fibrillation patients in Japan. -Subanalysis of the J-RHYTHM Registry. Circ J 2011 : 75 : 2357-62.
20) Katoh H, et al. Frequency and predictors of bleeding complications associated with anti-coagulant therapy using dabigatran in Japanese patients with atrial fibrillation. Am J Cardiovasc Dis 2014 ; 4 : 70-8.
21) Westenbrink BD, et al. Anemia predicts thromboembolic events, bleeding complications and mortality in patients with atrial fibrillation : Insights from the RE-LY trial. J Thromb Haemost 2015 ; 13 : 699-707.
P.239 掲載の参考文献
1) Defaye P, et al. Prevalence of supraventricular arrhythmia from the automated analysis of data stored in the DDD pacemakers of 617 patients : The AIDA study. The AIDA Multicenter Study Group. Automatic Interpretation for Diagnosis Assistance. Pacing Clin Electrophysiol 1998 ; 21 : 250-5.
2) Glotzer TV, et al. Atrial high rate episode detected by pacemaker diagnostics predict death and stroke : Report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). Circulation 2003 ; 107 : 1614-9.
7) Varma N, et al. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up : The Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation 2010 ; 122 : 325-32.
P.244 掲載の参考文献
9) 安岡良文, 柴田幸美. MRI対応デバイス, Heart View 2017 ; 21 : 158-66.
11) 日本不整脈心電学会. ICD・CRT-D植込み後の自動車の運転制限に関して. new.jhrs.or.jp/public/pub-icd-crt/
P.248 掲載の参考文献
P.252 掲載の参考文献
2) Clement CH, et al. ICRP publication 118 : ICRP Statement on Tissue Reactions/Early and Late Effects of Radiation in Normal Tissues and Organs-Threshold Doses for Tissue Reactions in a Radiation Protection Context. Ann ICRP 2012 ; 41 : 1-322.
3) 日本循環器学会. 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告) : 循環器診療における放射線被ばくに関するガイドライン (2011年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2011_nagai_rad_h.pdf
8) Ueda A, Epicardial access and ventricular tachycardia ablation in a postmyocarditis patient using a non-fluoroscopic catheter visualization system. Heart Rythm Case Rep 2017 ; 3 : 411-4.
9) Thibault B, et al. Reducing Radiation Exposure During CRT Implant Procedures : Single-Center Experience with Low-Dose Fluoroscopy Settings and a Sensor-based Navigation System (MediGuide). J Cardiovasc Electrophysiol 2016 Jul 26. doi : 10.1111/jce.13048. [Epub ahead of print]

第5章 さまざまな不整脈 - 病態に応じた治療の実際

P.258 掲載の参考文献
P.266 掲載の参考文献
3) Leyva F, et al. Outcomes of cardiac resynchronization therapy with or without defibrillation in patients with nonischemic cardiomyopathy. J Am Coll Cardiol 2017 ; 70 : 1216-27.
4) Dusman RE, et al. Clinical features of amiodarone-induced pulmonary toxicity. Circulation 1990 ; 82 : 51-9.
5) Domanski MJ, et al. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID investigators. Antiarrhythmics Versus Implantable Defibrillators. J Am Coll Cardiol 1999 ; 34 : 1090-5.
6) Yokoshiki H, et al. Prognostic significance of non-sustained ventricular tachycardia in patients receiving cardiac resynchronization therapy for primary prevention : Analysis of the Japan cardiac device treatment registry database. J Arrhythm 2018 ; 34 : 139-47.
P.274 掲載の参考文献
P.282 掲載の参考文献
1) 日本循環器学会. 循環器病の診断と治療に関するガイドライン (2011年合同研究班報告) : 肥大型心筋症の診療に関するガイドライン (2012年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2012_doi_h.pdf
2) 日本循環器学会. 循環器病の診断と治療に関するガイドライン (2009年合同研究班報告) : 心臓突然死の予知と予防法のガイドライン (2010年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2010aizawa.h.pdf
5) Olivotto I, et al, Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 2001 ; 104 : 2517-24.
7) 日本循環器学会. 循環器病の診断と治療に関するガイドライン (2008年度合同研究班報告) : 不整脈薬物治療に関するガイドライン (2009年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2009_kodama_h.pdf
9) 日本循環器学会. 循環器病の診断と治療に関するガイドライン (2012年度合同研究班報告) : 心房細動治療 (薬物) ガイドライン (2013年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2013_inoue_h.pdf
14) O'Mahony C, et al. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). Eur Heart J 2014 ; 35 : 2010-20.
15) Wang W, et al. Prognostic Implications of Nonsustained Ventricular Tachycardia in High-Risk Patients With Hypertrophic Cardiomyopathy. Circ Arrhythm Electrophysiol 2017 ; 10 (3). pii : e004604.
17) 日本循環器学会. 循環器病の診断と治療に関するガイドライン (2011年度合同研究班報告) : 失神の診断・治療ガイドライン (2012年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2012_inoue_h.pdf
19) 日本循環器学会. 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告) : 不整脈の非薬物治療ガイドライン (2011年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2011_okumura_h.pdf
20) Dukkipati SR, et al. Long-term outcomes of combined epicardial and endocardial ablation of monomorphic ventricluar tachycardia related to hypertrophic cardiomyopathy. Circ Arrhythm Electrophysiol 2011 ; 4 : 185-94.
23) O'Mahony C, et al. The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy. Heart 2012 ; 98 : 116-25.
24) Syska P, et al. Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy : Efficacy and complications of the therapy in tong-term follow-up. J Cardiovasc Electrophysiol 2010 ; 21 : 883-9.
26) Srinivasan NT, et al. Disease Severity and Exercise Testing Reduce Subcutaneous Implantable Cardioverter-Defibrillator Left Sternal ECG Screening Success in Hypertrophic Cardiomyopathy. Circ Arrhythm Electrophysiol 2017 ; 10 (4). pii : e004801.
P.290 掲載の参考文献
7) Mazzanti A, et al. Arrhythmogenic right ventricular cardiomyopathy : Clinical course and predictors of arrhythmic risk. J Am Coll Cardiol 2016 ; 68 : 2540-50.
P.300 掲載の参考文献
1) Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death : A distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992 ; 20 : 1391-6.
2) Wilde AA, et al. Proposed diagnostic criteria for the Brugada syndrome : Consensus report. Circulation 2002 ; 106 : 2514-9.
4) Antzelevitch C, Yan GX. J wave syndromes. Heart Rhythm 2010 ; 7 : 549-58.
6) Antzelevitch C. The Brugada syndrome : Ionic basis and arrhythmia mechanisms. J Cardiovasc Electrophysiol 2001 ; 12 : 268-72.
7) 日本循環器学会. 循環器病の診断と治療に関するガイドライン (2011年度合同研究班報告) : QT延長症候群 (先天性・二次性) とBrugada症候群の診療に関するガイドライン (2012年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2013_aonuma_d.pdf
11) Antzelevitch C, et al. J-Wave syndromes expert consensus conference report : Emerging concepts and gaps in knowledge. Europace 2017 19 : 665-94.
12) 日本循環器学会. 循環器病の診断と治療に関するガイドライン (2010年度合同研究班報告) : 不整脈の非薬物治療ガイドライン (2011年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2011_okumura_h.pdf
P.312 掲載の参考文献
1) Shimizu W. Clinical impact of genetic studies in lethal inherited cardiac arrhythmias. Circ J 2008 ; 72 : 1926-36.
2) Schwartz PJ, Crotti L. QTc behavior during exercise and genetic testing for the long-QT syndrome. Circulation 2011 ; 124 : 2181-4.
6) Sumitomo N, et al. Calcium channel blocker and adenosine triphosphate terminate bidirectional ventricular tachycardia in a patient with Andersen-Tawil syndrome. Heart Rhythm 2008 ; 5 : 498-9.
7) 日本循環器学会. 2016-2017年度活動 : 遺伝性不整脈の診療に関するガイドライン (2017年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2017_aonuma_h.pdf.
8) Leenhardt A, et al. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation 1995 ; 91 : 1512-9.
10) Priori SG, et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001 ; 103 : 196-200.
12) Aizawa Y, et al. Distinct U wave changes in patients with catecholaminergic polymorphic ventricular tachycardia (CPVT). Int Heart J 2006 ; 47 : 381-9.
13) Sumitorno N, et al. Association of atrial arrhythmia and sinus node dysfunction in patients with catecholaminergic polymorphic ventricular tachycardia. Circ J 2007 ; 71 : 1606-9.
16) Laitinen PJ, et al. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 2001 ; 103 : 485-90.
17) Lahat H, et al. Autosomal recessive catecholamine-or exercise-induced polymorphic ventricular tachycardia : Clinical features and assignment of the disease gene to chromosome 1p13-21. Circulation 2001 ; 103 : 2822-7.
24) Hwang HS, et al. Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia. Circ Arrhythm Electrophysiol 2011 ; 4 : 128-35.
25) Kobayashi S, et al. Dantrolene, a therapeutic agent for malignant hyperthermia, inhibits catecholaminergic polymorphic ventricular tachycardia in a RyR2 (R2474S/+) knock-in mouse model. Circ J 2010 ; 74 : 2579-84.
26) Sumitomo N, et al. Adenosine triphosphate terminates bidirectional ventricular tachycardia in a patient with catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 2008 ; 5 : 496-7.
28) Sumitomo N, et al. Clinical effectiveness of pulmonary vein isolation for arrhythmic events in a patient with catecholaminergic polymorphic ventricular tachycardia. Heart Vessels 2010 ; 25 : 448-52.
Schwartz PJ, et al. Diagnostic criteria for the long QT syndrome. An update. Circulation 1993 ; 88 : 782-4.
P.321 掲載の参考文献
1) Maisel WH, et al. Atrial fibrillation after cardiac surgery. Ann Intern Med 2001 ; 135 : 1061-73.
4) Blommaert D, et al. Effective prevention of atrial fibrillation by continuous atrial overdrive pacing after coronary artery bypass surgery. J Am Coll Cardiol 2000 ; 35 : 1411-5.
5) De Decker K, et al. Cardiac complications after noncardiac thoracic surgery : An evidence-based current review. Ann Thorac Surg 2003 ; 75 : 1340-8.

第6章 Current Topics - 診断と治療の最新動向

P.328 掲載の参考文献
1) Kleemann T, et al. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over aperiod of > 10 years. Circulation 2007 ; 115 : 2474-80.
4) Poole JE, Gold MR. Who should receive the subcutaneous implanted defibrillator? : The subcutaneous implantable cardioverter defibrillator (ICD) should be considered in all ICD patients who do not require pacing. Circ Arrhythm Electrophysiol 2013 ; 6 : 1236-44.
5) Al-Khatib SM, et al. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Heart Rhythm 2017 Oct 30. pii : S1547-5271 (17) 31249-3. doi : 10.1016/j.hrthm. 2017. 10. 035. [Epub ahead of print]
P.332 掲載の参考文献
P.335 掲載の参考文献
P.341 掲載の参考文献
1) Beck H, et al. 50th anniversary of the first successful permanent pacemaker implantation in the United States : Historical review and future directions. Am J Cardiol 2010 ; 106 : 810-8.
2) 日本不整脈心電学会. リードレスペースメーカ Micra 使用要件等基準. http://new.jhrs.or.jp/guideline/statement201709_01/
3) Reynolds D, et al. A leadless intracardiac transcatheter pacing system. N Engl J Med 2016 ; 374 : 533-41.
6) Bagai J, Zhao D. Subcutaneous "figure-of-eight" stitch to achieve hemostasis after removal of large-caliber femoral venous sheaths. Cardiac Interv Today 2008 : 22-3.
P.345 掲載の参考文献
1) Tanaka Y, et al. Utility of high-resolution electroanatomic mapping of the left ventricle using a multispline basket catheter in a swine model of chronic myocardial infarction. Heart Rhythm 2015 ; 12 : 144-54.
P.350 掲載の参考文献

最近チェックした商品履歴

Loading...